Roche launches Institute of Human Biology for human model systems to advance research and drug development
May 5, 2023 -- Roche on Thursday announced the launch of the Institute of Human Biology (IHB), focused on advancing medical research through human model systems such as organoids. Using human model systems, the IHB aims to accelerate drug discovery and development through understanding how diseases develop and organs function. Read More
Theratechnologies data suggests tesamorelin may improve metabolic profiles in people with HIV
March 6, 2023 -- Biopharma firm Theratechnologies recently presented data suggesting that tesamorelin, a growth hormone-releasing hormone analogue, may improve metabolic profiles in people with by reducing excess visceral abdominal fat (EVAF). Read More
Quanterix expands laboratory-developed-test menu with launch of neurofilament light chain test
January 11, 2023 -- Quanterix on Monday announced the validation of a laboratory developed test (LDT) to quantitatively measure neurofilament light chain (NfL) in serum as an aid in the evaluation of individuals for possible neurodegenerative conditions or other causes of neuronal or central nervous system damage. Read More
Grail launches methylation-based liquid biopsy solution for cancer research in a post-diagnosis setting
January 10, 2023 -- Grail on Monday announced the availability of a research-use-only offering for biopharmaceutical companies. The firm is leveraging a targeted methylation platform to analyze cell-free DNA (cfDNA) isolated from peripheral blood for cancer signal interrogation. Read More
Blood test helps diagnose inaccessible brain tumors
January 3, 2023 -- A prospective, blinded study by London’s Imperial College researchers showed the TriNetra-Glio liquid biopsy test, which requires 15 mL of blood, can detect malignant brain tumors. Read More
Prenetics acquiring majority stake in ACT Genomics, expanding position in cancer genetics, precision oncology
December 19, 2022 -- Hong Kong-based Prenetics Global, a genomics and diagnostic testing firm, on Friday announced that it is acquiring a majority stake in Taiwan-based precision oncology firm ACT Genomics. Read More
Cofactor Genomics kicks off study of multidimensional immune biomarker assay for NSCLC
December 15, 2022 -- Cofactor Genomics on Wednesday announced the commencement of a study of its OncoPrism assay in non-small cell lung cancer (NSCLC). Read More
Study: Menarini’s CellSearch technology effective in measuring and monitoring CTC levels in multiple myeloma
December 15, 2022 -- Single-cell technology and liquid biopsy developer Menarini Silicon Biosystems on Wednesday announced results from a study published December 7 in Cancer Discovery demonstrating that the enumeration and genomic characterization of circulating tumor cells (CTCs) at varying stages of multiple myeloma (MM) is invaluable in predicting disease aggressiveness and pathology. Read More
Novel peptide targets Alzheimer’s disease years before symptoms
December 12, 2022 -- New research demonstrates a novel synthetic peptide’s ability to selectively detect and neutralize an early molecular trigger of Alzheimer’s disease, with an eye towards early diagnosis and treatment of other amyloid diseases. Read More
AI uncovers molecular mechanism underlying pancreatic cancer
December 12, 2022 -- Researchers in Japan have mapped the binding site of the (pro)renin receptor known to be involved in pancreatic cancer development using an artificial intelligence (AI)-based protein structure prediction program. Read More
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter